96 related articles for article (PubMed ID: 18473839)
1. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
2. Development of protease inhibitors for protozoan infections.
McKerrow JH; Rosenthal PJ; Swenerton R; Doyle P
Curr Opin Infect Dis; 2008 Dec; 21(6):668-72. PubMed ID: 18978536
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid biosynthesis as a target for novel antibacterials.
Heath RJ; Rock CO
Curr Opin Investig Drugs; 2004 Feb; 5(2):146-53. PubMed ID: 15043388
[TBL] [Abstract][Full Text] [Related]
4. Using Structure-guided Fragment-Based Drug Discovery to Target
Arif SM; Floto RA; Blundell TL
Front Mol Biosci; 2022; 9():857000. PubMed ID: 35433835
[TBL] [Abstract][Full Text] [Related]
5. Fatty Acid Biosynthesis in Chromerids.
Tomčala A; Michálek J; Schneedorferová I; Füssy Z; Gruber A; Vancová M; Oborník M
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722284
[TBL] [Abstract][Full Text] [Related]
6. Genomics of apicomplexan parasites.
Swapna LS; Parkinson J
Crit Rev Biochem Mol Biol; 2017 Jun; 52(3):254-273. PubMed ID: 28276701
[TBL] [Abstract][Full Text] [Related]
7. Discovery of an allosteric inhibitor binding site in 3-Oxo-acyl-ACP reductase from Pseudomonas aeruginosa.
Cukier CD; Hope AG; Elamin AA; Moynie L; Schnell R; Schach S; Kneuper H; Singh M; Naismith JH; Lindqvist Y; Gray DW; Schneider G
ACS Chem Biol; 2013 Nov; 8(11):2518-27. PubMed ID: 24015914
[TBL] [Abstract][Full Text] [Related]
8. The endosymbiotic origin, diversification and fate of plastids.
Keeling PJ
Philos Trans R Soc Lond B Biol Sci; 2010 Mar; 365(1541):729-48. PubMed ID: 20124341
[TBL] [Abstract][Full Text] [Related]
9. Structure-based ligand design and the promise held for antiprotozoan drug discovery.
Hunter WN
J Biol Chem; 2009 May; 284(18):11749-53. PubMed ID: 19103598
[TBL] [Abstract][Full Text] [Related]
10. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
Docampo R; Moreno SN
Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
[TBL] [Abstract][Full Text] [Related]
11. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
12. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthesis in protozoan parasites: unusual pathways and novel drug targets.
Goodman CD; McFadden GI
Curr Pharm Des; 2008; 14(9):901-16. PubMed ID: 18473839
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
15. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
